Hydase

Active Ingredient(s): Hyaluronidase
FDA Approved: * October 25, 2005
Pharm Company: * PRIMAPHARM
Category: Medical Device

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Hydase Overview

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). Karl Meyer classified these enzymes in 1971 into three distinct groups, a scheme based on the enzyme reaction products.[1] The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.[2] In humans, there are five functional hyaluronidases: HYAL1, HYAL2, HYAL3, HYAL4 and HYAL5 (also known as...

Read more Hydase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Hyaluronidase

Recent Hydase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Hyaluronidase
  • Injection: 1,500 units/vial, 150 units/ml, 150 units/vial, 150unit/ml, 150USPunits/ml, 200 units/vial, 200units/ml, 6,200 units/vial
  • Powder for Reconstitution: 6200IU/5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Hydase: (1 result)

Sorted by National Drug Code
  • 17478-560 Hydase 150 [usp'u]/Ml Infiltration; Interstitial; Intramuscular; Intraocular; Retrobulbar; Subcutaneous Injection, Solution by Akorn, Inc.

Other drugs which contain Hyaluronidase or a similar ingredient: (8 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA